Standardization of Syndrome Differentiation Defined by Traditional Chinese Medicine in Operative Breast Cancer: A Modified Delphi Study

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td align="left">Proposal</td><td align="center">Opinion</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td align="left">Extended to two weeks</td><td align="center">55.56%</td></tr><tr><td align="left">Extended to one week</td><td align="center">27.78%</td></tr><tr><td align="left">Extended to one month</td><td align="center">16.67%</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

The experts’ opinions on the time length of perichemotherapy/radiotherapy in the first round investigation.

The Scientific World Journal

tab2

Table 2

Table 2: Standardization of Syndrome Differentiation Defined by Traditional Chinese Medicine in Operative Breast Cancer: A Modified Delphi Study 